Segnalazioni dalla Commissione Europea sulle azioni anti-Covid19

Coronavirus: per un'Europa pronta alla crescente minaccia delle varianti

(...) Con il nuovo piano europeo di preparazione alla difesa biologica contro le varianti della COVID-19, denominato "HERA Incubator", sarà avviata una collaborazione con ricercatori, aziende di biotecnologie, produttori e autorità pubbliche nell'UE e a livello mondiale per individuare le nuove varianti, incentivare lo sviluppo di vaccini adattati e nuovi, accelerarne il processo di approvazione e aumentare la capacità produttiva. (...)

---

Coronavirus: approvato dalla Commissione il secondo contratto con Moderna per garantire fino a 300 milioni di dosi supplementari (...) 

---

L'UE raddoppia il suo contributo allo strumento COVAX, portandolo a 1 miliardo di €, per garantire vaccini sicuri ed efficaci contro la COVID-19 per i paesi a basso e medio reddito 

---

Coronavirus: preparing Europe for the increased threat of variants

17/02/2021 - Consumer affairs and public health / Covid-19

The new European bio-defence preparedness plan against COVID-19 variants called “HERA Incubator” will work with researchers, biotech companies, manufacturers and public authorities in the EU and globally to detect new variants, provide incentives to develop new and adapted vaccines, speed up the approval process for these vaccines, and ensure scaling up of manufacturing capacities.

PHOTOS AND VIDEOS

• Communication from the Commission
• Questions and answers
• Factsheet
• Safe COVID-19 vaccines for Europeans
• EU Coronavirus response

 

Coronavirus: Commission approves second contract with Moderna to ensure up to additional 300 million doses

17/02/2021 - Consumer affairs and public health / Covid-19

The European Commission has approved a second contract with the pharmaceutical company Moderna, which provides for an additional purchase of 300 million doses (150 million in 2021 and an option to purchase an additional 150 million in 2022) on behalf of all EU Member States.

• Safe COVID-19 Vaccines for Europeans
• EU Vaccines Strategy
• EU Coronavirus Response
• Overview of the Commission's Response

 

EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

19/02/2021 - Covid-19 / International aid, development and cooperation

The European Union has announced an additional €500 million for the COVAX Facility, doubling its contribution to date for the global initiative that is leading efforts to secure fair and equitable access to safe and effective COVID-19 vaccines in low and middle-income countries.

• EU Global Response to coronavirus